Ananas comosus L. leaf phenols and p-coumaric acid regulate liver fat metabolism by upregulating CPT-1 expression

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Xie, Weidong ^a   Zhang, Shaobo ^b   Lei, Fan ^c   Ouyang, Xiaoxi ^a   Du, Lijun ^c  

^a TSINGHUA UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; MESSENGER RNA; OLEIC ACID; PARA COUMARIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHENOL DERIVATIVE; PINEAPPLE LEAF PHENOL DERIVATIVE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; HUMAN; HUMAN CELL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER METABOLISM; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PEROXISOME; PINEAPPLE; PLANT LEAF; PROTEIN EXPRESSION; UPREGULATION;

EID: 84907255144     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/903258     Document Type: Article

References (34)

1. Li Z., Xue J., Chen P., Chen L., Yan S., Liu L., Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. Journal of Gastroenterology and Hepatology 2014 29 42 51
2. Lawlor D. A., Callaway M., Macdonald-Wallis C., Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. Journal of Clinical Endocrinology and Metabolism 2014 99 3 E410 E417 10.1210/jc.2013-3612
3. Nakamura A., Terauchi Y., Lessons from mouse models of high-fat diet-induced NAFLD. International Journal of Molecular Sciences 2013 14 21240 21257
4. Kotronen A., Yki-Järvinen H., Männistö S., Saarikoski L., Korpi-Hyövälti E., Oksa H., Saltevo J., Saaristo T., Sundvall J., Tuomilehto J., Peltonen M., Non-alcoholic and alcoholic fatty liver disease-two diseases of affluence associated with the metabolic syndrome and type 2 Diabetes: the FIN-D2D survey. BMC Public Health 2010 10, article 237 10.1186/1471-2458-10-237 2-s2.0-77951954751
5. Nakajima K., Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty Liver disease. International Journal of Hepatology 2012 2012 13 950693 10.1155/2012/950693
6. Zambon A., Cusi K., The role of fenofibrate in clinical practice. Diabetes and Vascular Disease Research 2007 4 3 S15 S20 10.3132/dvdr.2007.053 2-s2.0-35548979848
7. Fernández-Miranda C., Pérez-Carreras M., Colina F., López-Alonso G., Vargas C., Solís-Herruzo J. A., A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. Digestive and Liver Disease 2008 40 3 200 205 10.1016/j.dld.2007.10.002 2-s2.0-38749085998
8. Eslami L., Merat S., Malekzadeh R., Nasseri-Moghaddam S., Aramin H., Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Cochrane Database Systematic Reviews 2013 12 CD008623
9. Song L. L., Administrant department of national Chinese traditional medicine. Chinese Herbs 1999 8 Shanghai, China 296 297. (Chinese)
10. Xie W., Xing D., Sun H., Wang W., Ding Y., Du L., The effects of Ananas comosus L. leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high-cholesterol diet. The American Journal of Chinese Medicine 2005 33 1 95 105 10.1142/S0192415X05002692 2-s2.0-16344361940
11. Xie W., Wang W., Su H., Xing D., Cai G., Du L., Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: different from fibrates but similar to statins. Journal of Pharmacological Sciences 2007 103 3 267 274 10.1254/jphs.FP0061244 2-s2.0-33947538750
12. Zammit V. A., Carnitine palmitoyltransferase 1: central to cell function. IUBMB Life 2008 60 5 347 354 10.1002/iub.78 2-s2.0-46749146865
13. Aires C. C. P., IJlst L., Stet F., Prip-Buus C., de Almeida I. T., Duran M., Wanders R. J. A., Silva M. F. B., Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochemical Pharmacology 2010 79 5 792 799 10.1016/j.bcp.2009.10.011 2-s2.0-72149113307
14. Derdak Z., Villegas K. A., Harb R., Wu A. M., Sousa A., Wands J. R., Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. Journal of Hepatology 2013 58 4 785 791 10.1016/j.jhep.2012.11.042 2-s2.0-84880925312
15. Tsuruta Y., Nagao K., Kai S., Tsuge K., Yoshimura T., Koganemaru K., Yanagita T., Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. Lipids in Health and Disease 2011 10, article 202 10.1186/1476-511X-10-202 2-s2.0-80655139138
16. Xie W.D., Wang H., Zhang J. F., Kung H. F., Zhao Y. N., Zhang Y., Proteomic profile of visceral adipose tissues between low-fat diet-fed obesity-resistant and obesity-prone C57BL/6 mice. Molecular Medicine Reports 2010 3 6 1047 1052 10.3892/mmr.2010.354 2-s2.0-78649489933
17. Wang W., Ding Y., Xing D., Wang J., Du L., Studies on phenolic constituents from leaves of pineapple (Ananas comosus). Zhongguo Zhongyao Zazhi 2006 31 15 1242 1244 2-s2.0-33846312472
18. Meng Z., Wang W., Xing D., Lei F., Lan J., Du L., Pharmacokinetic study of p -coumaric acid in mouse after oral administration of extract of Ananas comosus L. leaves. Biomedical Chromatography 2006 20 9 951 955 10.1002/bmc.626 2-s2.0-33748929333
19. Xie W., Gu D., Li J., Cui K., Zhang Y., Effects and action mechanisms of berberine and rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS ONE 2011 6 9 e24520 10.1371/journal.pone.0024520 2-s2.0-80052479571
20. Iossa S., Lionetti L., Mollica M. P., Crescenzo R., Barletta A., Liverini G., Effect of long-term high-fat feeding on energy balance and liver oxidative activity in rats. British Journal of Nutrition 2000 84 3 377 385 2-s2.0-0033796676
21. Xie W., Wang H., Zhang J., Nali J., Can Y., Qing L., Kung H., Zhang Y., Enhanced peroxisomal β -oxidation metabolism in visceral adipose tissues of high-fat diet-fed obesity-resistant C57BL/6 mice. Experimental and Therapeutic Medicine 2011 2 2 309 315 10.3892/etm.2011.208 2-s2.0-79551615168
22. Zhang X., Yang J., Guo Y., Ye H., Yu C., Xu C., Xu L., Wu S., Sun W., Wei H., Gao X., Zhu Y., Qian X., Jiang Y., Li Y., He F., Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Hepatology 2010 51 4 1190 1199 10.1002/hep.23486 2-s2.0-77950625001
23. Guo Y., Jolly R. A., Halstead B. W., Baker T. K., Stutz J. P., Huffman M., Calley J. N., West A., Gao H., Searfoss G. H., Li S., Irizarry A. R., Qian H., Stevens J. L., Ryan T. P., Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed Using rodent and canine hepatocytes. Toxicological Sciences 2007 96 2 294 309 10.1093/toxsci/kfm009 2-s2.0-33947226779
24. Bruce C. R., Brolin C., Turner N., Cleasby M. E., Van Der Leij F. R., Cooney G. J., Kraegen E. W., Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. The American Journal of Physiology-Endocrinology and Metabolism 2007 292 4 E1231 E1237 10.1152/ajpendo.00561.2006 2-s2.0-34047223522
25. Schreurs M., Kuipers F., van der Leij F. R., Regulatory enzymes of mitochondrial β -oxidation as targets for treatment of the metabolic syndrome. Obesity Reviews 2010 11 5 380 388 10.1111/j.1467-789X.2009.00642.x 2-s2.0-77951126550
26. Srivastava R. A. K., Pinkosky S. L., Filippov S., Hanselman J. C., Cramer C. T., Newton R. S., AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. Journal of Lipid Research 2012 53 12 2490 2514 10.1194/jlr.R025882 2-s2.0-84869021501
27. Fedorenko A., Lishko P. V., Kirichok Y., Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 2012 151 2 400 413 10.1016/j.cell.2012.09.010 2-s2.0-84867564026
28. Rakhshandehroo M., Knoch B., Müller M., Kersten S., Peroxisome proliferator-activated receptor alpha target genes. PPAR Research 2010 2010 20 612089 10.1155/2010/612089 2-s2.0-78349283454
29. Morris E. M., Jackman M. R., Meers G. M., Reduced hepatic mitochondrial respiration following acute high-fat diet is prevented by PGC-1 overexpression. American Journal of Physiology: Gastrointestinal and Liver Physiology 2013 305 G868 G880
30. Miyazaki M., Nakagawa I., Koga S., Kasahara Y., Patricelli M. P., Proteomics analysis of cardiac muscle from rats with peroxisomal proliferator-activated receptor a (PPARalpha) stimulation. Journal of Toxicological Sciences 2010 35 1 131 135 10.2131/jts.35.131 2-s2.0-76749095472
31. Song S., Attia R. R., Connaughton S., Niesen M. I., Ness G. C., Elam M. B., Hori R. T., Cook G. A., Park E. A., Peroxisome proliferator activated receptor (PPAR ) and PPAR gamma coactivator (PGC-1 ) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements. Molecular and Cellular Endocrinology 2010 325 1-2 54 63 10.1016/j.mce.2010.05.019 2-s2.0-77954385136
32. van der Leij F. R., Bloks V. W., Grefhorst A., Hoekstra J., Gerding A., Kooi K., Gerbens F., te Meerman G., Kuipers F., Gene expression profiling in livers of mice after acute inhibition of β -oxidation. Genomics 2007 90 6 680 689 10.1016/j.ygeno.2007.08.004 2-s2.0-36549009674
33. Koo S. H., Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clinical Molecular Hepatology 2013 19 210 215 10.3350/cmh.2013.19.3.210
34. Sumida Y., Niki E., Naito Y., Yoshikawa T., Involvement of free radicals and stress. Free Radical Research 2013 47 869 880